Skip to content

FELIX PHARMA

Active
Public limited companyfounded 200224 yrs activeRue Montavaux 155, 7080 Frameries, BelgiumKBO/BCE: BE 0477.939.091
Summary

FELIX PHARMA has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €560,583 and a net result of €201. Equity remains stable across the filed fiscal years (±0.2% per year). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability38=
Solvency100=
Growth58=
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40,000 at 30 days acceptable
short-term debt: 0.1% and cash: 30.4% of total assets, and 0.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 24 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
99.9%
Return on assets
0%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 d early
2024
5 d early
2023
8 d early
2022
5 d early
2021
77 d early
2020
71 d early
2019
88 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 41 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 25 July (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

FELIX PHARMA was incorporated on 9 July 2002.1 Total assets went from EUR 565,298 in 2019 to EUR 560,983 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€201▼ 47.4%
2024 · €382
Working capital
€170,193
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result-€764▼ 85.0%-€2,780▼ 264%-€721▲ 74.1%-€753▼ 4.4%-€750▲ 0.4%
Net result-€894▼ 65.6%-€3,004▼ 236%-€861▲ 71.3%€382€201▼ 47.4%
Equity€563,864▼ 0.2%€560,860▼ 0.5%€559,999▼ 0.2%€560,382▲ 0.1%€560,583=
Total assets€563,864▼ 0.2%€560,860▼ 0.5%€559,999▼ 0.2%€560,382▲ 0.1%€560,983▲ 0.1%
Debt€400
Working capital€170,193
Result per fiscal year
Operating resultNet result
-€4,000-€3,000-€2,000-€1,000€0Operating result 2021: -€764-€764Net result 2021: -€894-€894Operating result 2022: -€2,780-€2,780Net result 2022: -€3,004-€3,004Operating result 2023: -€721-€721Net result 2023: -€861-€861Operating result 2024: -€753-€753Net result 2024: €382€382Operating result 2025: -€750-€750Net result 2025: €201€20120212022202320242025-€1,000-€500€0€500Operating result 2023: -€721-€721Net result 2023: -€861-€861Operating result 2024: -€753-€753Net result 2024: €382€382Operating result 2025: -€750-€750Net result 2025: €201€201202320242025
The operating result stays negative: a loss of €750 in 2025 against €753 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €560,983
Fixed assets €390,390 =
Current assets €170,593 ▲ 0.4%
Equity and liabilities €560,983
Equity €560,583
Debt €400
Debt finances 0.1% of the balance-sheet total.
Key figures and ratios
2025 value · change against 2024
Debt to equity
0.00
ROE
0.0%▼
2024 · 0.1%
ROA
0.0%▼
2024 · 0.1%
Debt ≤ 1 year
€400
Income taxes
€485▼
2024 · €551
A ratio outside any meaningful range has been withheld (balance sheet total €560,983, equity €560,583).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 32 lines
Balance sheet Code20242025
Assets
Total assets20/58€560,382€560,983▲
Fixed assets21/28€390,390€390,390=
Financial fixed assets28€390,390€390,390=
Current assets29/58€169,992€170,593▲
Cash at bank and in hand54/58€169,572€170,354▲
Deferred charges and accrued income490/1€420€239▼
Equity and liabilities
Total equity and liabilities10/49€560,382€560,983▲
Equity10/15€560,382€560,583=
Contributions10/11€500,000€500,000=
Capital10€500,000€500,000=
Issued capital100€500,000€500,000=
Reserves13€50,000€50,000=
Non-distributable reserves130/1€50,000€50,000=
Legal reserve130€50,000€50,000=
Profit (loss) carried forward14€10,382€10,583▲
Amounts payable17/49-€400
Amounts payable within one year42/48-€400
Trade debts44-€400
Suppliers440/4-€400
Income statement Code20242025
Other operating charges640/8-€400
Gross operating margin9900-€753-€350▲
Operating profit (loss)9901-€753-€750▲
Financial income75/76B€1,836€1,616▼
Recurring financial income75€1,836€1,616▼
Financial charges65/66B€150€180▲
Recurring financial charges65€150€180▲
Profit (loss) for the period before taxes9903€933€686▼
Income taxes67/77€551€485▼
Profit (loss) for the period9904€382€201▼
Profit (loss) for the period to be appropriated9905€382€201▼
Appropriation of the result
Profit (loss) to be appropriated9906€10,382€10,583▲
Profit (loss) brought forward from the previous period14P€10,000€10,382▲

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Other operating charges640/8----€400-
Gross operating margin9900-€764-€2,780-€721-€753-€350▲ 53.5%
Operating profit (loss)9901-€764-€2,780-€721-€753-€750▲ 0.4%
Financial income75/76B--€14€1,836€1,616▼ 12.0%
Recurring financial income75--€14€1,836€1,616▼ 12.0%
Non-recurring financial income76B--€14---
Financial charges65/66B-€224€150€150€180▲ 20.0%
Recurring financial charges65€130€224€150€150€180▲ 20.0%
Profit (loss) for the period before taxes9903-€894-€3,004-€857€933€686▼ 26.5%
Income taxes67/77--€4€551€485▼ 12.0%
Profit (loss) for the period9904-€894-€3,004-€861€382€201▼ 47.4%
Profit (loss) for the period to be appropriated9905-€894-€3,004-€861€382€201▼ 47.4%
Line20212022202320242025Change
Assets
Total assets20/58€563,864€560,860€559,999€560,382€560,983▲ 0.1%
Fixed assets21/28€390,390€390,390€390,390€390,390€390,390=
Financial fixed assets28€390,390€390,390€390,390€390,390€390,390=
Current assets29/58€173,474€170,470€169,609€169,992€170,593▲ 0.4%
Cash at bank and in hand54/58€173,474€170,470€169,609€169,572€170,354▲ 0.5%
Deferred charges and accrued income490/1---€420€239▼ 43.1%
Equity and liabilities
Total equity and liabilities10/49€563,864€560,860€559,999€560,382€560,983▲ 0.1%
Equity10/15€563,864€560,860€559,999€560,382€560,583=
Contributions10/11€500,000€500,000€500,000€500,000€500,000=
Capital10--€500,000€500,000€500,000=
Issued capital100--€500,000€500,000€500,000=
Reserves13€50,000€50,000€50,000€50,000€50,000=
Non-distributable reserves130/1-€50,000€50,000€50,000€50,000=
Legal reserve130--€50,000€50,000€50,000=
Reserves not available under the articles1311-€50,000----
Profit (loss) carried forward14€13,864€10,860€9,999€10,382€10,583▲ 1.9%
Amounts payable17/49----€400-
Amounts payable within one year42/48----€400-
Trade debts44----€400-
Suppliers440/4----€400-
Line20212022202320242025Change
Profit (loss) for the period9904-€894-€3,004-€861€382€201▼ 47.4%
Operating cash flow (approximation)-€894-€3,004-€861€382€201▼ 47.4%
Investment in fixed assets (approximation)-€0€0€0€0-
Change in cash--€3,004-€861-€37€782▲ 2,214%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-06
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
26-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Back to profitnet €382
Net result €382 after 5 loss-making years.
23-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
26-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Weakest financial yearnet -€3,004
Net result drops to -€3,004, the lowest in the series; recovery starts the following year.
2021
15-11
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2020
21-11
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2019
04-11
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2018
07-11
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2017
04-12
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2016
22-12
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts

We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Frameries · 1 establishment unit since 2003
seat establishment approximate The establishment unit on the map
Ground area
7,555 m²
Building footprint
5,250 m²
Volume, LiDAR
24,831 m³
2 parcels, Wallonia · tallest building 6.3 m, ±2 floors. Linked by address, not a title deed.
24 companies at this address See who is registered here
1 establishment unit
LES TELLIERS
Rue des Telliers **, 7000 MonsNACE 70111
since 20032.133.331.094
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
53028A0282/00E003 Wallonia 7,354 m² 1 · 5,065 m² 6.3 m · 2 fl.
53403E0077/00G000indicative Wallonia 201 m² 1 · 185 m² -
Linked by address, not proof of ownership
Good to know
1 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPublic limited company
Founded09-07-2002
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:0477939091
Also 9925:BE0477939091

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.